Book contents
- Advance Praise for The Cambridge Handbook of Public-Private Partnerships, Intellectual Property Governance, and Sustainable Development
- The Cambridge Handbook of Public–Private Partnerships, Intellectual Property Governance, and Sustainable Development
- The Cambridge Handbook of Public–Private Partnerships, Intellectual Property Governance, and Sustainable Development
- Copyright page
- Contents
- Figures
- Tables
- Contributors
- Foreword
- Acknowledgments
- Glossary
- Introduction
- Part I Public Health
- 2 Public–Private Partnerships as Models for New Drug Research and Development: The Future as Now
- 3 Driving Innovation for Global Health through Multi-stakeholder Partnerships
- 4 Creating, Managing, and Advancing Collaborations: The Road to Successful Partnerships
- 5 Patent Pooling in Public Health
- 6 Intellectual Property in Early-Phase Research Public–Private Partnerships in the Biomedical Sector
- Part II Education, ICT, and Libraries
- Part III Environmental Issues: Green Technologies and Agriculture
- Part IV Governance and Institutional Design Perspectives
- Conclusion
- References
3 - Driving Innovation for Global Health through Multi-stakeholder Partnerships
from Part I - Public Health
Published online by Cambridge University Press: 14 September 2018
Book contents
- Advance Praise for The Cambridge Handbook of Public-Private Partnerships, Intellectual Property Governance, and Sustainable Development
- The Cambridge Handbook of Public–Private Partnerships, Intellectual Property Governance, and Sustainable Development
- The Cambridge Handbook of Public–Private Partnerships, Intellectual Property Governance, and Sustainable Development
- Copyright page
- Contents
- Figures
- Tables
- Contributors
- Foreword
- Acknowledgments
- Glossary
- Introduction
- Part I Public Health
- 2 Public–Private Partnerships as Models for New Drug Research and Development: The Future as Now
- 3 Driving Innovation for Global Health through Multi-stakeholder Partnerships
- 4 Creating, Managing, and Advancing Collaborations: The Road to Successful Partnerships
- 5 Patent Pooling in Public Health
- 6 Intellectual Property in Early-Phase Research Public–Private Partnerships in the Biomedical Sector
- Part II Education, ICT, and Libraries
- Part III Environmental Issues: Green Technologies and Agriculture
- Part IV Governance and Institutional Design Perspectives
- Conclusion
- References
Summary
This chapter reviews the multi‑stakeholder partnership landscape in the context of the United Nations Sustainable Development Agenda as well as broader innovation incentive schemes, such as for neglected tropical diseases (NTDs). It looks at some economic determinants of innovation and studies how different partnership models endeavor to address related challenges. WIPO Re:Search is presented as one recent initiative with the potential to create partnership networks to catalyze research and development in NTDs, malaria, and TB.
- Type
- Chapter
- Information
- The Cambridge Handbook of Public-Private Partnerships, Intellectual Property Governance, and Sustainable Development , pp. 47 - 71Publisher: Cambridge University PressPrint publication year: 2018
References
Barnes, Jeffrey, Designing Public–Private Partnerships in Health, SHOPS (2011), www.abtassociates.com/reports/PPP_Primer.pdf.Google Scholar
BIO Ventures for Global Health, 2015 Partnership Hub Mid-Year Report: Catalyzing Partnerships for Global Health (2015), www.wipo.int/export/sites/www/research/en/docs/bvgh_midyear_research_report_2015.pdf (last visited Nov. 18, 2017).Google Scholar
BIO Ventures for Global Health, Partnership Hub Mid-Year Report 2017, https://bvgh.org/wp-content/uploads/2017/09/2017-BVGH-Partnership-Hub-Mid-Year-Report.pdf (last visited Nov. 18, 2017).Google Scholar
Bombelles, Thomas (Interview by Coaker, Hannah), Neglected Tropical Disease Research: Rethinking the Drug Discovery Model, 7 Future Medicinal Chemistry 7 (2015).Google Scholar
Bombelles, Thomas, Dent, Jennifer, Sharafudeen, Meghana, Stevens, Philip, Graef, Katy M., and Krattiger, Anatole, WIPO Re:Search: Sharing Innovation in the Fight Against Neglected Tropical Diseases (2015), www.wipo.int/edocs/pubdocs/en/wipo_pub_gc_8.pdf (last visited Nov. 18, 2017).Google Scholar
Brant, Jennifer and Parthasarathy, Balaji, The Dynamics of Global Technology and Knowledge Flows, (Innovation and Intellectual Prop. Series, Research Paper No. 4, 2015).Google Scholar
Cashwell, Amber, Tantri, Anupama, Schmidt, Ashley, Simona, Greg, and Mistrya, Neeraj. BRICS in the Response to Neglected Tropical Diseases, 92 Bulletin of the World Health Org. (2014).Google Scholar
Cookson, Clive, Studies Fuel Criticism of High Drug Development Costs, Fin. Times, April 9, 2015, www.ft.com/content/6a57fcd4-bdcd-11e4-8cf3-00144feab7de?mhq5j=e5.Google Scholar
Dent, Jennifer, Graef, Katy M., and Shivanand, Paddy, Open Innovation to Bolster Research and Development for Neglected and Emerging Infectious Diseases, 1 J. Med. Dev. (2015) Available at http://ojs.whioce.com/index.php/jmds/article/view/119/99 (last visited Nov. 18, 2017).Google Scholar
Deloitte Centre for Health Solutions, Measuring the Return from Pharmaceutical Innovation 2014, Deloitte (2014) https://www2.deloitte.com/uk/en/pages/life-sciences-and-healthcare/articles/measuring-the-return-from-pharmaceutical-innovation-2014.html (last visited Nov. 18, 2017).Google Scholar
Drugs for Neglected Diseases Initiative, An Innovative Approach to R&D for Neglected Patients: Ten Years of Experience & Lessons Learned by DNDi (2014) www.dndi.org/wp-content/uploads/2009/03/DNDi_Modelpaper_2013.pdf (last visited Nov. 18, 2017).Google Scholar
Farlow, Andrew, The Global HIV Vaccine Enterprise, Malaria Vaccines, and Purchase Commitments: What is the Fit? (2005) www.who.int/intellectualproperty/submissions/Farlow.pdf. note 14.Google Scholar
Grace, Cheri, Product Development Partnerships (PDPs): Lessons from PDPs Established to Develop New Health Technologies for Neglected Diseases, Human Dev. Res. Ctr. (2010).Google Scholar
Hotez, Peter J., The Neglected Tropical Diseases and the Neglected Infections of Poverty: Overview of Their Common Features, Global Disease Burden and Distribution, New Control Tools, and Prospects for Disease Elimination, in The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Opportunities for Integrated Intervention Strategies (Institute of Medicine (US) Forum on Microbial Threats ed., 2011).Google Scholar
House of Commons Science and Technology Committee, Building Scientific Capacity for Development, 2012–13, HC 377 (UK).Google Scholar
Idris, Kamil, and Arai, Hisamitsu, The Intellectual Property-Conscious Nation: Mapping the Path from Developing to Developed (2006).Google Scholar
Jedrusik, Ania, Sharing Innovation and Building Capacity to Fight Neglected Tropical Diseases: A Selection of WIPO Re:Search Fellowship Stories, Global Challenges Rep. (2016), www.wipo.int/edocs/pubdocs/en/wipo_pub_gc_11.pdf (last visited Nov. 18, 2017).Google Scholar
Jewell, Cathy, Harnessing the Power of the Private Sector – An Interview with Francis Gurry, 5 WIPO Mag., Oct. 2015.Google Scholar
Krattiger, Anatole, Mahoney, Richard T., Nelsen, Lita, Thomson, Jennifer A., Bennett, Alan B., Satyanarayana, Kanikaram, Graff, Gregory D., Fernandez, Carlos, and Kowalski, Stanle P. (eds.), Intellectual Property Management of Health and Agricultural Innovation: A handbook of Best Practices (2007).Google Scholar
Lansang, Mary Ann, and Dennis, Rodolfo, Building Capacity in Health Research in the Developing World, 82 Bulletin of the World Health Org. (2004).Google Scholar
Mahoney, Richard, Product Development Partnerships: Case Studies of a New Mechanism for Health Technology Innovation, 9 Health Res. Pol’y and Sys. (2011).Google Scholar
Mahoney, Richard, Strategic Review of WIPO Re:Search, Global Challenges Rep. (2015), www.ip-watch.org/weblog/wp-content/uploads/2015/10/WIPO-GlobalChallenges-ReSearch-Review-Oct-2015.pdf (last visited Nov. 18, 2017).Google Scholar
Mattes, William B., (Chaguturu, Rathnam ed.), Divided We Fall, in Collaborative Innovation in Drug Discovery: Strategies for Public and Private Partnerships (2014).Google Scholar
Molyneux, David H., Hotez, Peter J, and Fenwick, Alan, “Rapid-Impact Interventions”: How a Policy of Integrated Control for Africa’s Neglected Tropical Diseases Could Benefit the Poor, PLoS Med (2005).Google Scholar
Morel, Carlos M., Acharya, Tara, Broun, Denis, Dangi, Ajit, Elias, Christopher, Ganguly, N. K., Gardner, Charles A., Gupta, R. K., Haycock, Jane, Heher, Anthony D., Hotez, Peter J., Kettler, Hannah E., Keusch, Gerald T., Krattiger, Anatole F., Kreutz, Fernando T., Lall, Sanjaya, Lee, Keun, Mahoney, Richard, Martinez-Palomo, Adolfo, Mashelkar, R. A., Matlin, Stephen A., Mzimba, Mandi, Oehler, Joachim, Ridley, Robert G., Senanayake, Pramilla, Singer, Peter, and Yun, Mikyung, Health Innovation Networks to Help Developing Countries Address Neglected Diseases, 309 Science (2005).CrossRefGoogle ScholarPubMed
OECD, Coherence for Health: Innovation for New Medicines for Infectious Diseases, The Development Dimension (2009).Google Scholar
Policy Cures, Global Funding of Innovation for Neglected Diseases: G-FINDER (2015) http://policycures.org/gfinder.html (last visited Nov. 18, 2017).Google Scholar
Policy Cures, Measuring Global Health R&D for the Post-2015 Development Agenda (2015) www.ghtcoalition.org/pdf/Measuring-global-health-R-D-for-the-post-2015-development-agenda.pdf (last visited Nov. 18, 2017).Google Scholar
Ramamoorthi, Roopa, et al., WIPO Re:Search: Accelerating Anthelmintic Development through Cross-Sector Partnerships, 4 Int. J. for Parasitology: Drugs & Drug Resistance (2014).Google Scholar
Symposium, Anthelmintics: From Discovery to Resistance (2016); Symposium, Global Challenges for New Drug Discovery Against Tropical Parasitic Diseases (2014).Google Scholar
Reich, Michael R., Public–Private Partnerships for Public Health, 6 Nature Med. 617 (2000).CrossRefGoogle ScholarPubMed
Savioli, Lorenzo, Montresor, Antonio, and Gabrielli, Albis F., Neglected Tropical Diseases: The Development of a Brand with No Copyright. A Shift from a Disease-Centered to a Tool-Centered Strategic Approach, in The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Opportunities for Integrated Intervention Strategies: Workshop Summary (2011), www.ncbi.nlm.nih.gov/books/NBK62524/ (last visited Nov. 18, 2017)Google Scholar
Taubman, Antony, A Typology of Intellectual Property Management for Public Health Innovation and Access: Design Considerations for Policy Makers, 4 The Open AIDS J. 1 (2010).Google Scholar
Torstensson, David, Fighting Tropical Disease: It’s Now a Common Cause, PharmExec.com (Feb. 8, 2012), www.pharmexec.com/fighting-tropical-disease-its-now-common-cause.Google Scholar
Tufts Ctr. for the Study of Drug Dev., Press Release, Cost to Develop and Win Marketing Approval for a New Drug Is $2.6 Billion (November 18, 2014), http://csdd.tufts.edu/news/complete_story/pr_tufts_csdd_2014_cost_study (last visited Nov. 18, 2017).Google Scholar
Uniting to Combat Neglected Tropical Diseases, Country Leadership and Collaboration on Neglected Tropical Diseases: Third Progress Report of the London Declaration (2015) http://unitingtocombatntds.org/sites/default/files/document/UTCNTD%20FULL%20REPORT.pdf.Google Scholar
Uniting to Combat Neglected Tropical Diseases, London Declaration on Neglected Tropical Diseases (2012) http://unitingtocombatntds.org/sites/default/files/resource_file/london_declaration_on_ntds.pdf (last visited Nov. 18, 2017).Google Scholar
Uniting to Combat Neglected Tropical Diseases, http://unitingtocombatntds.org/ (last visited Nov. 18, 2017).Google Scholar
World Health Organization [WHO], Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases - A Roadmap for Implementation: Executive Summary (2012), www.who.int/neglected_diseases/NTD_RoadMap_2012_Fullversion.pdf.Google Scholar
WHO, First Global Partners’ Meeting on Neglected Tropical Diseases, www.who.int/neglected_diseases/partners_meeting/en/ (last visited Nov. 18, 2017).Google Scholar
WHO, Health in 2015: from MDGs to SDGs (2015), http://apps.who.int/iris/bitstream/10665/200009/1/9789241565110_eng.pdf?ua=1 (last visited Nov. 18, 2017).Google Scholar
WHO, Making a Difference: 30 Years of Research and Capacity Building in Tropical Diseases (2007), http://apps.who.int/iris/bitstream/10665/43689/1/9789241595575_eng.pdf (last visited Nov. 18, 2017).Google Scholar
WHO, Neglected Tropical Diseases Summary, WHO (2017), www.who.int/neglected_diseases/diseases/summary/en/ (last visited Nov. 18, 2017).Google Scholar
WHO, Neglected Tropical Diseases, Hidden Successes, Emerging Opportunities (2006), http://apps.who.int/iris/bitstream/10665/69367/1/WHO_CDS_NTD_2006.2_eng.pdf (last visited Nov. 18, 2017).Google Scholar
WHO, Public Health, Innovation and Intellectual Property Rights; Report of the Commission on Intellectual Property Rights, Innovation and Public Health (2006), www.who.int/intellectualproperty/documents/thereport/ENPublicHealthReport.pdf (last visited Nov. 18, 2017).Google Scholar
WHO Comm’n on Intellectual Prop. Rights, Public Health: Innovation and Intellectual Property Rights ( 2006), www.who.int/intellectualproperty/documents/thereport/ENPublicHealthReport.pdf?ua=1 (last visited Nov. 18, 2017).Google Scholar
WHO, WIPO & WTO, Promoting Access to Medical Technologies and Innovation: Intersections between Public Health, Intellectual Property, and Trade (2012), www.wto.org/english/res_e/booksp_e/pamtiwhowipowtoweb13_e.pdf (last visited Nov. 18, 2017).Google Scholar
World Intellectual Property Organization [WIPO], The 45 Adopted Recommendations under the WIPO Development Agenda, www.wipo.int/ip-development/en/agenda/recommendations.html (last visited April 10, 2016).Google Scholar
WIPO, The First Five Years of the WIPO Japan Funds-in-Trust for Industrial Property (Japan FIT/IP) for Africa and Least Developed Countries (LDCs): A Productive Collaboration with the Japan Patent Office (JPO) (2013), www.wipo.int/export/sites/www/cooperation/en/funds_in_trust/docs/japanfitip_jpo_firstfiveyears_en.pdf (last visited Nov. 18, 2017).Google Scholar
- 1
- Cited by